In this study, two colorectal cancer cell lines, HCT116 and DLD-1, were used in which the AKT isoforms, AKT1 and AKT2, have been knocked out with no residual protein expression, which enables the analyses of the different AKT isoforms to be more reliable. The gene discussed is AKT2; the disease is colorectal cancer.